The term GLP-1 agonist wriggled its way into our vocabulary with the discovery that weekly injections of semaglutide, the active ingredient in Ozempic and Wegovy, can cause significant weight loss
Try to resist doing things that might delay the healing process
This allowed us to identify a link between raised IGF-I levels and an increased risk for thyroid cancer in this UK cohort. says lead investigator, Dr Anika Knuppel of NDPH
Although potassium can leave the cell when the receptors open, the electrochemical gradient driving sodium ion movement is stronger than the gradient driving potassium movement, resulting in a depolarization of the membrane potential
Some people experience more severe reactions, including gallbladder problems, pancreatitis, or gastrointestinal issues
This is why most diet-only approaches see weight regain beginning within the first year, while GLP-1 medications extend the active loss phase to 18 to 24 months or longer